Three RingsThe lawsuit -- made public just days after one of Barnum's alleged trips -- accuses Caremark of defrauding and endangering state customers by, among other things, selling them drugs that were returned through the mail by others but never tested for possible damage. It now claims that Florida prosecutors originally declined to join the case at Barnum's suggestion. Moreover, it says that Barnum never told the attorney general's office about his ties to Caremark when offering his advice. Florida's official code of ethics requires agency officials to refuse and disclose any gifts valued at more than $25 from influential parties. Just this month, the St. Petersburg Times reported, Florida suspended two other government employees after it learned they had taken trips funded by companies that conduct business with the state. Caremark, which acts as the pharmacy benefit manager for Florida's 200,000-plus state customers, has a far larger contract than those other vendors. Kuczwanski described the two incidents as "completely separate," involving different circumstances, although he is unfamiliar with details surrounding the earlier suspensions. He also told TheStreet.com earlier this week that Barnum could not personally comment on the matter because of pending litigation between Caremark and the state of Florida. Recently, the state reversed its stand -- at the company's request -- and filed a motion to assume control of the whistleblower lawsuit. The state portrayed itself as better-suited to handle the case than current plaintiffs Michael and Peppi Fowler, who could soon face an administrative hearing for alleged misconduct. In its own legal documents also filed on Thursday, Caremark elaborated by saying that Peppi Fowler had displayed a "long pattern of deceit and disloyalty" and "materially breached her confidentiality agreement with Caremark" by obtaining thousands of pages worth of patient information that are now being used in the whistleblower lawsuit. Caremark also claims that both Fowlers defrauded the company and violated multiple laws by illegally obtaining huge quantities of highly addictive painkillers at the company's expense for a relative. Looking ahead, Caremark hopes to depose Peppi Fowler a second time because the company claims that Leonard earlier hindered the discovery process by issuing "frivolous and lengthy objections" and restricting his client from answering some highly relevant questions. It still wants a response to, among other things, whether the plaintiff was aware that her attorneys "offered Caremark the chance to keep the lawsuit under seal if they would pay multi million dollars to settle it." It also wants to know what the plaintiff said when she met with the attorney general's office. Critics now suspect that the attorney general is actually more interested in derailing the whistleblower lawsuit than pursuing Caremark. They point out that companies don't normally invite prosecution. And they are particularly troubled by the fact that the law firm now representing Caremark until last year employed the very prosecutor who is now seeking control of the case. Barnum's ties to the company make them more suspicious than ever. Meanwhile, Caremark is apparently trying to keep more than Barnum's deposition from the public. "Caremark has filed an injunction action ... attempting to stop the Florida A.G.'s office from producing the documents that Caremark provided to that office," Leonard said. "Looks like they are trying to play it both ways -- using their relationship with the A.G.'s office while trying to shield what they gave" to that same office.